St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

By analyzing multiple emphysema and COPD patient datasets, SPP1 is significantly upregulated in the lungs of patients, ...

Pulmonx Corporation’s LUNG share price has surged by 32.23%, which has investors questioning if this is right time to sell.

Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...

This study is led by Dr. Lianyong Han and Dr. Tobias Stoeger in Germany (Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, German Research ...

According to the American Lung Association ... with 3.5 million also diagnosed with emphysema, which is life-threatening with no cure. The new treatment, the Zephyr Valve, aims to help ease ...

Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study ...

Many Part D prescription drug plans cover Trelegy Ellipta, but costs can vary by plan type and insurer. Read more.

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...